In short. Periorbital rejuvenation with injectables combines skin boosters, micro-volume filler and a muscle-relaxing injectable to treat the thin skin around the eyes. Each component addresses a different problem and none fixes all of them. Because the skin here is the thinnest on the face and the area is vascular, treatment is staged in small volumes.
Key points
- Periorbital injectables combine skin boosters, micro-volume filler and a muscle-relaxing injectable.
- Each component treats a different problem, and none fixes all of them.
- Filler placed into fluid-driven puffiness makes it worse, and festoons predictably backfire.
- Results are temporary: toxin months, filler six to twelve months, boosters a course.
- Vision change or severe pain after an eye-area injection is an emergency.
What does periorbital rejuvenation treat?
Periorbital rejuvenation refers to injectable treatments around the eyes, an area that often shows ageing first. Because the skin here is the thinnest on the face and the anatomy is delicate, the honest answer is usually a careful combination of small treatments rather than one big one: skin boosters for skin quality, micro-volume filler where there is genuine hollowing, and botulinum toxin for crow's feet lines caused by muscle movement. Results are temporary, and restraint is the defining skill.
The assessment separates problems that look alike
The area around the eye has thin skin, little padding, important vessels, and complex fluid drainage. Assessment must first separate problems that look similar but need different treatment: true hollows under the eye (tear troughs), puffiness caused by fat or fluid, malar bags or festoons, dark circles from pigment or visible vessels, and lines from muscle movement. Filler placed into fluid-driven puffiness makes it worse, not better.
How each component works
Skin boosters deliver tiny amounts of hyaluronic acid into the skin itself to improve hydration and fine crepey texture. Micro-volume filler, used conservatively, can soften a true tear trough hollow. Botulinum toxin relaxes the muscle responsible for crow's feet. Each targets a different problem; none fixes all of them.
| Component or finding | What it is for | What to expect | What it does not do |
|---|---|---|---|
| Skin boosters | Hydration and fine crepey texture | A short course with gradual improvement | Soften a hollow or relax muscle |
| Micro-volume filler | A true tear trough hollow | Immediate, settling over two weeks, lasting roughly 6 to 12 months | Suit fluid-driven puffiness or festoons |
| Botulinum toxin | Crow's feet lines caused by muscle movement | Effects over several days, lasting around three to four months | Treat texture loss or hollowing |
| Fluid-driven puffiness and festoons | Filler makes the first worse and predictably backfires in the second | Prolonged puffiness can follow filler in fluid-prone areas | Be treated by injection |
| Loose excess skin or significant fat prolapse | May need surgical or other approaches | Assessed as a separate problem | Be corrected by an injectable |
Who does it suit, and who needs something else?
Good candidates have realistic goals and problems that match the tools: hollowing, fine texture loss, or movement lines. People whose main issue is loose excess skin, significant fat prolapse, or festoons may need surgical or other approaches, and an honest consultation will say so.
How long do the results last?
Botulinum toxin effects appear over several days and last around three to four months. Skin boosters are usually a short course with gradual improvement. Filler results are immediate but settle over two weeks, lasting roughly 6 to 12 months in this area. Mild swelling and bruising are common because the skin is thin and vascular.
Risks near the eye
Bruising and swelling are the everyday risks. Specific to this area: filler placed superficially can show as bluish lumps, and filler in fluid-prone areas can cause prolonged puffiness. Vascular occlusion is a rare but serious risk of any filler, and injections near the eye carry the rarest and gravest risk of all, vision complications, which is why injector qualifications and emergency protocols matter more here than almost anywhere else.
Urgent review after an eye-area injection
Severe pain, skin blanching, or a mottled, dusky colour change after injection needs urgent medical review. So does any change in vision, double vision, or pain in or around the eye, which is an emergency. Persistent or worsening puffiness or lumps under the eye in the weeks after filler also need review.
How treatment is planned over time
The periorbital area is often managed as a programme: botulinum toxin maintained three to four times a year, skin boosters in periodic courses, and filler only where indicated and reviewed carefully. A qualified medical consultation always comes first. A clinic that declines to inject filler into festoons or fluid-driven puffiness, where it predictably backfires, is applying that same restraint rather than refusing care.
Sources
- American Academy of Dermatology: patient information on injectable treatments around the eyes
- U.S. Food and Drug Administration: approved dermal filler and neurotoxin products
- Cochrane Library: systematic reviews on periorbital rejuvenation
Internal links
Frequently asked questions
Why is one treatment not enough around the eyes?
Problems that look similar need different tools — skin boosters address fine crepey texture, micro-volume filler softens a true tear trough hollow, and botulinum toxin relaxes the muscle that creates the lines at the outer eye. Each targets a different problem and none fixes all of them.
When is filler the wrong choice around the eye?
When the puffiness is fluid-driven. Filler placed into fluid-driven puffiness makes it worse, not better, and filler in festoons predictably backfires. People whose main issue is loose excess skin or significant fat prolapse may need surgical or other approaches.
What are the specific risks of injecting near the eye?
Bruising and swelling are the everyday risks. Filler placed superficially can show as bluish lumps, and filler in fluid-prone areas can cause prolonged puffiness. Vascular occlusion is rare but serious, and injections near the eye carry the gravest risk of all, vision complications.
Risks & Limitations
- Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
- Nodules, lumps or granuloma formation, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
- Bruising and swelling. All injectable results are temporary and maintenance is required.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing.
- Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
- National Medical Products Administration (NMPA, China) — approved product status
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.